Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Copper in Gynecological Diseases

Version 1 : Received: 22 November 2023 / Approved: 23 November 2023 / Online: 23 November 2023 (11:17:31 CET)

A peer-reviewed article of this Preprint also exists.

Conforti, R.A.; Delsouc, M.B.; Zorychta, E.; Telleria, C.M.; Casais, M. Copper in Gynecological Diseases. Int. J. Mol. Sci. 2023, 24, 17578. Conforti, R.A.; Delsouc, M.B.; Zorychta, E.; Telleria, C.M.; Casais, M. Copper in Gynecological Diseases. Int. J. Mol. Sci. 2023, 24, 17578.

Abstract

Copper (Cu) is an essential micronutrient for the correct development of eukaryotic organisms. This metal plays a key role in many cellular and physiological activities, including enzymatic activity, oxygen transport, and cell signaling. Although the redox activity of Cu is crucial for enzymatic reactions, this property also makes it potentially toxic when found at high levels. Due to this dual action of Cu, highly regulated mechanisms are necessary to prevent both the deficiency and the accumulation of this metal since its dyshomeostasis may favor the development of multiple diseases, such as Menkes’ and Wilson’s diseases, neurodegenerative diseases, diabetes mellitus, and cancer. As the relationship between Cu and cancer has been the most studied, we analyze how this metal can affect three fundamental processes for tumor progression: cell proliferation, angiogenesis, and metastasis. Gynecological diseases are characterized by high prevalence, morbidity, and mortality, depending on the case, and mainly include benign and malignant tumors. The cellular processes that promote their progression are affected by Cu, and the mechanisms that occur may be similar. We analyze the crosstalk between Cu deregulation and gynecological diseases, focusing on therapeutic strategies derived from this metal.

Keywords

copper; gynecological diseases; Cu chelators; Cu ionophores; ovarian cancer; polycystic ovarian syndrome; cervical cancer; endometrial cancer; endometriosis

Subject

Medicine and Pharmacology, Reproductive Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.